[Malignant neuroleptic syndrome].
D000328:Adult; D014150:Antipsychotic Agents / Q000009:adverse effects*; D001794:Blood Pressure / Q000187:drug effects; D001831:Body Temperature / Q000187:drug effects; D003243:Consciousness / Q000187:drug effects; D005260:Female; D006220:Haloperidol / Q000009:adverse effects*; D006801:Humans; D008297:Male; D008875:Middle Aged; D011605:Psychoses, Substance-Induced / Q000209:etiology* / Q000517:prevention & control; D012120:Respiration Disorders / Q000139:chemically induced; D012559:Schizophrenia / Q000150:complications / Q000188:drug therapy*; D013577:Syndrome; D013610:Tachycardia / Q000139:chemically induced
D014150:Antipsychotic Agents; D006220:Haloperidol
Det maligne neuroleptikasyndrom.